Disclosures for "Sex-based Differences in the Clinical Presentation and Outcomes of Posterior Reversible Encephalopathy Syndrome: A Nationwide Analysis"
-
Dr. Pekyi-Boateng has nothing to disclose.
-
Dr. Gabel has nothing to disclose.
-
Dr. Flavin has nothing to disclose.
-
Ms. Badu-Prempeh has nothing to disclose.
-
Kamleshun Ramphul has nothing to disclose.
-
Dr. Duodu has nothing to disclose.
-
Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qualtrics Inc. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Azurity Pharmaceuticals. Dr. Rubinos has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for American Epilepsy Society . Dr. Rubinos has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Marinus Pharmaceutical. Dr. Rubinos has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for American Epilepsy Society . The institution of Dr. Rubinos has received research support from University of North Carolina .
-
Dr. Wold has nothing to disclose.